Isolation of stem cell populations with trophic and immunoregulatory functions from human intestinal tissues: potential for cell therapy in inflammatory bowel disease

References

• Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276:71–4.
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, . Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284:143–7.
   PubMed Web of Science ®Google Scholar
• Baksh D, Song L, Tuan RS. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 2004; 8:301–16.
   PubMed Web of Science ®Google Scholar
• Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968; 6:230–47.
   PubMed Web of Science ®Google Scholar
• Oswald J, Boxberger S, Jørgensen B, Feldmann S, Ehninger G, Bornhäuser M, . Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 2004; 22:377–84.
   PubMed Web of Science ®Google Scholar
• Zipori D. The stem state: mesenchymal plasticity as a paradigm. Curr Stem Cell Res Ther 2006; 1:95–102.
   PubMedGoogle Scholar
• da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006; 119:2204–13.
   PubMed Web of Science ®Google Scholar
• Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, . A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008; 3:301–13.
   PubMed Web of Science ®Google Scholar
• Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 2007; 213:341–7.
   PubMed Web of Science ®Google Scholar
• Mackenzie TC, Flake AW. Human mesenchymal stem cells persist, demonstrate site-specific multipotential differentiation, and are present in sites of wound healing and tissue regeneration after transplantation into fetal sheep. Blood Cells Mol Dis 2001; 27:601–4.
   PubMed Web of Science ®Google Scholar
• Fox JM, Chamberlain G, Ashton BA, Middleton J. Recent advances into the understanding of mesenchymal stem cell trafficking. Br J Haematol 2007; 137:491–502.
   PubMed Web of Science ®Google Scholar
• Psaltis PJ, Zannettino A, Worthley SG, Gronthos S. Concise review. Mesenchymal stromal cells: potential for cardiovascular repair. Stem Cells 2008; 26:2201–10.
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, . Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008; 371:1579–86.
   PubMed Web of Science ®Google Scholar
• Lanzoni G, Roda G, Belluzzi A, Roda E, Bagnara GP. Inflammatory bowel disease: moving toward a stem cell-based therapy. World J Gastroenterol 2008; 14:4616–26.
   PubMed Web of Science ®Google Scholar
• Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, Saggio I, . Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007; 131:324–36.
   PubMed Web of Science ®Google Scholar
• Kaltz N, Funari A, Hippauf S, Delorme B, Noël D, Riminucci M, . In-vivo osteoprogenitor potency of human stromal cells from different tissues does not correlate with expression of POU5F1 or its pseudogenes. Stem Cells 2008; 26:2419–24.
   PubMedGoogle Scholar
• Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2008; 2:313–9.
   PubMed Web of Science ®Google Scholar
• Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, . Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005; 7:393–5.
   PubMed Web of Science ®Google Scholar
• Pierdomenico L, Bonsi L, Calvitti M, Rondelli D, Arpinati M, Chirumbolo G, . Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp. Transplantation 2005; 80:836–42.
   PubMed Web of Science ®Google Scholar
• Alviano F, Fossati V, Marchionni C, Arpinati M, Bonsi L, Franchina M, . Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC Dev Biol 2007; 7:11–.
   PubMed Web of Science ®Google Scholar
• US National Institutes of Health Database Available at: http://www.clinicaltrials.gov Accessed September 2008.
   Google Scholar
• Daher SR, Johnstone BH, Phinney DG, March KL. IFATS Series. Adipose stromal/stem cells: basic and translational advances. Stem Cells 2008; 26(10):2664–5.
   PubMedGoogle Scholar
• Parolini O, Alviano F, Bagnara GP, Bilic G, Bühring HJ, Evangelista M, . Concise review. Isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells 2008; 26:300–11.
   PubMed Web of Science ®Google Scholar
• Secco M, Zucconi E, Vieira NM, Fogaça LL, Cerqueira A, Carvalho MD, . Multipotent stem cells from umbilical cord: cord is richer than blood! Stem Cells 2008; 26:146–50.
   PubMed Web of Science ®Google Scholar
• Crisan M, Deasy B, Gavina M, Zheng B, Huard J, Lazzari L, . Purification and long-term culture of multipotent progenitor cells affiliated with the walls of human blood vessels: myoendothelial cells and pericytes. Methods Cell Biol 2008; 86:295–309.
   PubMed Web of Science ®Google Scholar
• Pasquinelli G, Tazzari PL, Vaselli C, Foroni L, Buzzi M, Storci G, . Thoracic aortas from multiorgan donors are suitable for obtaining resident angiogenic mesenchymal stromal cells. Stem Cells 2007; 25:1627–34.
   PubMed Web of Science ®Google Scholar
• Covas DT, Piccinato CE, Orellana MD, Siufi JL, Silva WA Jr, Proto-Siqueira R, . Mesenchymal stem cells can be obtained from the human saphena vein. Exp Cell Res 2005; 309:340–4.
   PubMed Web of Science ®Google Scholar
• Nasef A, Ashammakhi N, Fouillard L. Immunomodulatory effect of mesenchymal stromal cells: possible mechanisms. Regen Med 2008; 3:531–46.
   PubMed Web of Science ®Google Scholar
• Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, . Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99:3838–43.
   PubMed Web of Science ®Google Scholar
• Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003; 75:389–97.
   PubMed Web of Science ®Google Scholar
• Rasmusson I, Ringdén O, Sundberg B, Le Blanc K. Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp Cell Res 2005; 305:33–41.
   PubMed Web of Science ®Google Scholar
• Bocelli-Tyndall C, Bracci L, Spagnoli G, Braccini A, Bouchenaki M, Ceredig R, . Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro. Rheumatology (Oxford) 2007; 46:403–8.
   PubMed Web of Science ®Google Scholar
• Klyushnenkova E, Mosca JD, Zernetkina V, Majumdar MK, Beggs KJ, Simonetti DW, . T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J Biomed Sci 2005; 12:47–57.
   PubMed Web of Science ®Google Scholar
• Rizzo R, Campioni D, Stignani M, Melchiorri L, Bagnara GP, Bonsi L, . A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells. Cytotherapy 2008; 10:364–75.
   PubMed Web of Science ®Google Scholar
• Gerdoni E, Gallo B, Casazza S, Musio S, Bonanni I, Pedemonte E, . Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann Neurol 2007; 61:219–27.
   PubMed Web of Science ®Google Scholar
• Parekkadan B, Tilles AW, Yarmush ML. Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells. Stem Cells 2008; 26:1913–9.
   PubMed Web of Science ®Google Scholar
• Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006; 98:1076–84.
   PubMed Web of Science ®Google Scholar
• Phinney DG, Prockop DJ. Concise review. Mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair: current views. Stem Cells 2007; 25:2896–902.
   PubMed Web of Science ®Google Scholar
• Sémont A, François S, Mouiseddine M, François A, Saché A, Frick J, . Mesenchymal stem cells increase self-renewal of small intestinal epithelium and accelerate structural recovery after radiation injury. Adv Exp Med Biol 2006; 585:19–30.
   PubMed Web of Science ®Google Scholar
• Zhang J, Gong JF, Zhang W, Zhu WM, Li JS. Effects of transplanted bone marrow mesenchymal stem cells on the irradiated intestine of mice. J Biomed Sci 2008; 15:585–94.
   PubMedGoogle Scholar
• Andoh A, Zhang Z, Inatomi O, Fujino S, Deguchi Y, Araki Y, . Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 2005; 129:969–84.
   PubMed Web of Science ®Google Scholar
• Laroux FS, Grisham MB. Immunological basis of inflammatory bowel disease: role of the microcirculation. Microcirculation 2001; 8:283–301.
   PubMed Web of Science ®Google Scholar
• Khalil PN, Weiler V, Nelson PJ, Khalil MN, Moosmann S, Mutschler WE, . Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease. Gastroenterology 2007; 132:944–54.
   PubMedGoogle Scholar
• Tixier E, Lalanne F, Just I, Galmiche JP, Neunlist M. Human mucosa/submucosa interactions during intestinal inflammation: involvement of the enteric nervous system in interleukin-8 secretion. Cell Microbiol 2005; 7:1798–810.
   PubMedGoogle Scholar
• Ward SM, Sanders KM. Physiology and pathophysiology of the interstitial cell of Cajal: from bench to bedside. I. Functional development and plasticity of interstitial cells of Cajal networks. Am J Physiol Gastrointest Liver Physiol 2001; 281:G602–11.
   PubMed Web of Science ®Google Scholar
• Fiocchi C, Ina K, Danese S, Leite AZ, Vogel JD. Alterations of mesenchymal and endothelial cells in inflammatory bowel diseases. Adv Exp Med Biol 2006; 579:168–76.
   PubMed Web of Science ®Google Scholar
• Hatoum OA, Binion DG, Otterson MF, Gutterman DD. Acquired microvascular dysfunction in inflammatory bowel disease: loss of nitric oxide-mediated vasodilation. Gastroenterology 2003; 125:58–69.
   PubMed Web of Science ®Google Scholar